MedTrace Logo

PK of Depo SubQ Injected in the Upper Arm

NCT01143207 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2013-08-19

Study results available
· View outcomes & findings →

Summary

A single-arm trial to demonstrate that Depo-SubQ Provera injected in the upper arm is adequate for effective contraception

Conditions

  • Contraception

Interventions

DRUG

Medroxyprogesterone acetate

Injectable hormonal contraceptive

Sponsors & Collaborators

  • Eastern Virginia Medical School

    collaborator OTHER

  • FHI 360

    lead OTHER

Principal Investigators

  • David Archer, MD · Eastern Virginia Medical School

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01143207 on ClinicalTrials.gov